Surfactant therapy in neonates | Evidence, Current practice, and complications
The post outlines the Surfactant therapy for neonatal respiratory distress syndrome (RDS) or hyaline membrane disease (HMD). The following topics are covered
- Evidence
- Importance,
- How it is done - the procedure
- Complications of surfactant administration in newborns.
Power-point
Author
![about authors](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhwd_C2jDdaTZhqYoMMVddqACP22wjs8sa_tvUeS5vyLO7DuUSr_Peg7CkInKIvTfPE5gjCkZqFDAaFBUJ8aRicWTIBWFc8ieeYtwzB8gir29Bo95nbG1C47wtYDKKCMNOzBIZLW_PPquUW/s100/sharp+circle+bw+125.jpg)
Ajay Agade | DNB(Pediatrics), FNB(Pediatric Intensive Care), Fellowship in Pediatric pulmonology and LTV
Ajay is a Paediatric Intensivist, currently working in Pediatric Pulmonology & LTV at Great Ormond Street Hospital NHS, London
1 comment
🩺 Help us refine this article — share corrections or additional information below. Let's elevate the accuracy of knowledge together! 💉💬